Indication
Cancer-associated Thrombosis
3 clinical trials
5 products
Clinical trial
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisStatus: Recruiting, Estimated PCD: 2024-10-01
Product
EnoxaparinProduct
DalteparinProduct
TinzaparinClinical trial
Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) StudyStatus: Not yet recruiting, Estimated PCD: 2026-09-30
Product
AnticoagulantClinical trial
Long-term Treatment of Cancer Associated VTE: Reduced vs Full Dose of Apixaban : API-CAT STUDY for APIxaban Cancer Associated ThrombosisStatus: Active (not recruiting), Estimated PCD: 2024-09-06
Product
Apixaban